Anthropic进入药物研发——AI能解决Big Pharma 12年的失败率问题吗？
anthropic启动了针对被忽视疾病的内部药物发现项目以训练其ai，标志着其进军高风险生物学应用领域。
anthropic will conduct preclinical research for neglected diseases, citing its nonprofit mission and the need for complex training data to improve its ai models. the announcement accompanied the launch of 'claude science', a tool where a ucsf researcher reportedly used claude to identify a year-old viral contamination in minutes. this strategy aligns with broader industry efforts, such as google's isomorphic labs, to cut drug development timelines from 12 to 8 years.